Benchling, Inc.
Classification
Private
About
About
Benchling is a cloud-based platform dedicated to accelerating biotechnology research and development by providing integrated solutions for scientific data management, collaboration, and workflow automation. Its tools and services cater to life sciences companies, enhancing their R&D efficiency and data-driven decision-making. Product/Service Line Breakdown: 1. Notebook: An electronic lab notebook (ELN) designed for collaborative note-taking and experiment documentation. 2. Molecular Biology: Tools for DNA, RNA, and protein sequence design and analysis. 3. Registry: A centralized database for managing biological entities such as plasmids, cell lines, and antibodies. 4. Inventory: A system for tracking laboratory reagents and materials. 5. Workflows: Features to manage and automate R&D processes and experimental workflows. 6. Insights: Analytical tools for data visualization and reporting to derive actionable insights from experimental data. 7. Request Management: Tools for handling and tracking internal and external experiment requests. 8. Connect: An integration platform to connect and manage instrument data at scale.
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
Keywords
Keywords
Classified
Private